NCT06080971

Brief Summary

Describe demographic and clinical data of neonates \& childern with (PNNJ) admitted to neonatology , hepatology \& hematology units of Assiut university children hospital(AUCH). Describe the distribution of etiologies of (PNNG) in neonates \& children at AUCH. Assess the outcome of (PNNJ) in neonates \& childern admitted to AUCH .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

October 13, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

October 16, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

October 8, 2023

Last Update Submit

October 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Describe demographic and clinical data of neonates & childern with (PNNJ) admitted to neonatology , hepatology & hematology units of Assiut university children hospital(AUCH) Assess the outcome of (PNNJ) in neonates & childern admitted to AUCH .

    Describe the distribution of etiologies of (PNNG) in neonates \& children at AUCH.

    Baseline

Eligibility Criteria

Age14 Days - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

neonates and children with prolonged neonatal jaundice

You may qualify if:

  • All neonates and children with prolonged neonatal jaundice admitted to Neonatology , hepatology \& hematology units at Assiut university children hospital through the period from 1/1/2024 to 31/12/2024.

You may not qualify if:

  • Neonates with neonatal jaundice lasts less than 14 days in full term and 21 days in preterm infants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Siu SL, Chan LW, Kwong AN. Clinical and biochemical characteristics of infants with prolonged neonatal jaundice. Hong Kong Med J. 2018 Jun;24(3):270-276. doi: 10.12809/hkmj176990. Epub 2018 May 25.

    PMID: 29807952BACKGROUND
  • Feldman AG, Sokol RJ. Neonatal Cholestasis. Neoreviews. 2013 Feb 1;14(2):10.1542/neo.14-2-e63. doi: 10.1542/neo.14-2-e63.

    PMID: 24244109BACKGROUND
  • Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB, Heyman MB; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):115-28. doi: 10.1097/00005176-200408000-00001.

    PMID: 15269615BACKGROUND

MeSH Terms

Conditions

Jaundice, Neonatal

Condition Hierarchy (Ancestors)

Hyperbilirubinemia, NeonatalInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Elham Allam Ahmed

CONTACT

yasser farouk, professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
71515,Assiut

Study Record Dates

First Submitted

October 8, 2023

First Posted

October 12, 2023

Study Start

October 13, 2023

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

October 16, 2023

Record last verified: 2023-10